Adolescents and young adults

In recent years, adolescent and young adult oncology has emerged as a distinct field due to lack of progress in survival and quality-of-life outcomes (Ferrari et al. 2010; Smith et al. 2013). The significant developmental change that occurs during this life stage complicates a diagnosis of cancer, often leading to unique physical, social and emotional…

Read More

Members of the multidisciplinary team for head and neck cancer (formerly Appendix E)

The multidisciplinary team may include the following members: care coordinator (as determined by multidisciplinary team members)* medical oncologist* nurse (with appropriate expertise)* pathologist* radiation oncologist* radiologist/imaging specialist* urologist* Aboriginal health practitioner, Indigenous liaison officer or remote general practitioner clinical trials coordinator continence practitioner dietitian endocrinologist exercise physiologist fertility specialist general practitioner geriatrician nuclear medicine physician…

Read More

People experiencing socioeconomic disadvantage

In general, people from lower socioeconomic groups are at greater risk of poor health, have higher rates of illness, disability and death, and live shorter lives than those from higher socioeconomic groups (AIHW 2016). People experiencing socioeconomic disadvantage are less likely to participate in screening programs, more likely to be obese, less likely to exercise…

Read More

Optimal Care Pathways Steering Committee

Alfred Health Cancer Australia Cancer Council Victoria, Strategy and Support Division Cancer Institute New South Wales Concord Repatriation General Hospital New South Wales Consumer representative Department of Health Victoria, Commissioning and System Improvement Division, Cancer Unit National Cancer Expert Reference Group Olivia Newton-John Cancer Wellness and Research Centre St Vincent’s Hospital Melbourne Other stakeholders consulted…

Read More

6.3 Multidisciplinary team

If there is an indication that a patient’s cancer has returned, care should be provided under the guidance of a treating specialist. Each patient should be evaluated to determine if referral to the original multidisciplinary team is necessary. Often referral back to the original multidisciplinary team will not be necessary unless there are obvious aspects…

Read More

7.1 Multidisciplinary palliative care

If the treatment team does not include a palliative care member, the lead clinician should consider referring the patient to palliative care services, with the general practitioner’s engagement. This may include inpatient palliative unit access (as required). The multidisciplinary team may consider seeking additional expertise from these professionals: clinical psychologist clinical nurse specialist or practitioner…

Read More

6.2 Managing recurrent or metastatic disease

Managing recurrent or metastatic disease is complex and should therefore involve all the appropriate specialties in a multidisciplinary team including palliative care where appropriate. From the time of diagnosis, the team should offer patients appropriate psychosocial care, supportive care, advance care planning and symptom-related interventions as part of their routine care. The approach should be…

Read More

7.2 Research and clinical trials

Clinical trials may help improve palliative care and in managing a patient’s symptoms of advanced cancer (Cancer Council Victoria 2019). The treatment team should support the patient to participate in research and clinical trials where available and appropriate. For more information visit the Cancer Australia website. See ’Resource list’ for additional clinical trial databases.

Read More

6.1 Signs and symptoms of recurrent or metastatic disease

Some patients will have metastatic disease on initial presentation. Others may present with symptoms of recurrent disease after a previous cancer diagnosis. Access to the best available therapies, including clinical trials, as well as treatment overseen by a multidisciplinary team, are crucial to achieving the best outcomes for anyone with locally recurrent or metastatic disease.…

Read More